JP7303792B2 - 花粉破裂抑制用組成物 - Google Patents

花粉破裂抑制用組成物 Download PDF

Info

Publication number
JP7303792B2
JP7303792B2 JP2020506565A JP2020506565A JP7303792B2 JP 7303792 B2 JP7303792 B2 JP 7303792B2 JP 2020506565 A JP2020506565 A JP 2020506565A JP 2020506565 A JP2020506565 A JP 2020506565A JP 7303792 B2 JP7303792 B2 JP 7303792B2
Authority
JP
Japan
Prior art keywords
composition
pollen
acid
bursting
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020506565A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019176947A1 (ja
Inventor
唯 松原
毅 伊藤
昌宏 河畑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of JPWO2019176947A1 publication Critical patent/JPWO2019176947A1/ja
Application granted granted Critical
Publication of JP7303792B2 publication Critical patent/JP7303792B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/22Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2020506565A 2018-03-13 2019-03-12 花粉破裂抑制用組成物 Active JP7303792B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018045642 2018-03-13
JP2018045642 2018-03-13
PCT/JP2019/010036 WO2019176947A1 (ja) 2018-03-13 2019-03-12 花粉破裂抑制用組成物

Publications (2)

Publication Number Publication Date
JPWO2019176947A1 JPWO2019176947A1 (ja) 2021-03-18
JP7303792B2 true JP7303792B2 (ja) 2023-07-05

Family

ID=67906735

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020506565A Active JP7303792B2 (ja) 2018-03-13 2019-03-12 花粉破裂抑制用組成物

Country Status (4)

Country Link
JP (1) JP7303792B2 (zh)
CN (2) CN116440156A (zh)
TW (1) TWI814790B (zh)
WO (1) WO2019176947A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7114668B2 (ja) * 2020-10-08 2022-08-08 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002080314A (ja) 2000-06-19 2002-03-19 Santen Pharmaceut Co Ltd 防腐剤
JP2015071554A (ja) 2013-10-02 2015-04-16 ロート製薬株式会社 オロパタジン含有点眼剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE324910T1 (de) * 2000-06-19 2006-06-15 Santen Pharmaceutical Co Ltd Aseptische mittel

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002080314A (ja) 2000-06-19 2002-03-19 Santen Pharmaceut Co Ltd 防腐剤
JP2015071554A (ja) 2013-10-02 2015-04-16 ロート製薬株式会社 オロパタジン含有点眼剤

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
参天製薬株式会社,アレジオン点眼液0.05%,2017年
深川 和己 ほか,エピナスチン塩酸塩点眼液ベンザルコニウム塩化物(BAK)フリー製剤のスギ花粉の抗原溶出に対する影響,アレルギー・免疫,2016年01月19日,Vol.23, No.2,p.124-129, ISSN 1344-6932
野原修,スギ花粉からの主要抗原溶出に対する鼻汁の影響-In vitroにおける抗原溶出に影響を与える諸因子に,耳鼻咽喉科展望,1996年,Vol.39, No.5,p.483-495, ISSN 0386-9687

Also Published As

Publication number Publication date
TWI814790B (zh) 2023-09-11
JPWO2019176947A1 (ja) 2021-03-18
WO2019176947A1 (ja) 2019-09-19
CN111836627A (zh) 2020-10-27
TW202002994A (zh) 2020-01-16
CN116440156A (zh) 2023-07-18

Similar Documents

Publication Publication Date Title
JP7401503B2 (ja) 点眼型洗眼薬用組成物
JP7076183B2 (ja) ビタミンaを含有するエマルション点眼液
JP6315755B2 (ja) 異物感緩和点眼剤
JP2021178845A (ja) 眼科組成物
JP7303792B2 (ja) 花粉破裂抑制用組成物
JP2023033557A (ja) 複合目症状改善用眼科組成物
JPWO2019216381A1 (ja) 眼科組成物
JP2019065002A (ja) フェネチルアルコールと界面活性剤を含有するソフトコンタクトレンズ用の点眼又は洗眼液
JP6607976B2 (ja) 異物感緩和点眼剤
TWI847978B (zh) 點眼型洗眼藥用組合物
JP7178470B1 (ja) 眼科組成物
JP7421897B2 (ja) 親油性成分を含有する眼科組成物
JP2024059971A (ja) 洗眼剤組成物
JP2023008962A (ja) 眼科組成物
JP2022176930A (ja) 眼科組成物
JP2024072698A (ja) アレルギー用眼科組成物
JP2019218369A (ja) 異物感緩和点眼剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230421

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230530

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230623

R150 Certificate of patent or registration of utility model

Ref document number: 7303792

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150